Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017

Details for Mechanism ID: 17850
Country/Region: Angola
Year: 2017
Main Partner: Columbia University
Main Partner Program: Mailman School of Public Health
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $2,815,946 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $37,500
Care: TB/HIV (HVTB) $127,095
Care: Pediatric Care and Support (PDCS) $7,500
Strategic Information (HVSI) $1,454,189
Health Systems Strengthening (OHSS) $300,000
Testing: HIV Testing and Counseling (HVCT) $330,446
Treatment: Adult Treatment (HTXS) $495,669
Treatment: Pediatric Treatment (PDTX) $63,547
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 20,394
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 298
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 536
HTS_TST Service Delivery Point Agg Age (Facility) ANC: <15, Negative 2018 341
HTS_TST Service Delivery Point Agg Age (Facility) ANC: 15+, Negative 2018 1,023
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 22
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 28
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 411
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 226
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 43
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 63
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 651
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 322
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 282
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 399
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 4,702
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 2,391
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Female, Negative 2018 27
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Male, Negative 2018 29
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 616
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 369
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Female, Negative 2018 156
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Male, Negative 2018 241
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 2,759
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 1,619
HTS_TST Sum of Test Result disaggregates 2018 2,840
HTS_TST_POS By Test Result: Positive 2018 2,840
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 52
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 92
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: <15, Positive 2018 11
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: 15+, Positive 2018 32
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 221
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 122
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Positive 2018 11
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 163
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 80
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 48
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 68
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 804
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 408
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 117
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 70
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 413
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 54
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 41
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 384
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 42
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 508
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,082
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 975
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 46
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 425
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 46
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 565
TB_PREV By Age/Sex (Numerator): <15, Female 2018 30
TB_PREV By Age/Sex (Numerator): <15, Male 2018 23
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 494
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 202
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 749
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 1,070
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 43
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 32
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 706
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 289
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 285
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 3,022
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 278
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 4,006
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 7,591
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 8,203
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 285
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 3,339
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 332
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 4,247
TX_CURR Aggregated Age/Sex: <15 Female 2018 353
TX_CURR Aggregated Age/Sex: <15 Male 2018 292
TX_CURR Aggregated Age/Sex: 15+ Female 2018 5,920
TX_CURR Aggregated Age/Sex: 15+ Male 2018 2,512
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 9,077
TX_CURR Sum of Aggregated Age/Sex <15 2018 645
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 8,432
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 9,077
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 96
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 143
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 1,921
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,029
TX_NEW Breastfeeding status 2018 1
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,189
TX_NEW Pregnancy status 2018 14
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 3,189
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 4,397
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 3,519
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 170
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 149
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 2,164
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,036
TX_PVLS Numerator: Indication: Routine 2018 3,519
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 16
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 91
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 186
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 2,705
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,294
TX_PVLS_den Denominator: Indication: Routine 2018 4,397
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 20
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 69
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 98
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,297
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 711
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 2,175
TX_RET Numerator by Status: Pregnant 2018 69
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 2,717
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 86
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 121
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,622
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 888
TX_RET_den Denominator by Status: Pregnant 2018 84
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 7,111
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 353
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 15
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 10
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 232
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 96
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 219
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 182
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 4,710
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 2,000
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 107
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 248
TX_TB_den Denominator: By Screen Result: Negative 2018 6,400
TX_TB_den Denominator: By Screen Result: Positive 2018 711
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 355